Sunshine Biopharma Inc.
SBFM· Nasdaq
Filed May 7, 2015 · 10-Q · 37 days after period end · 0001354488-15-002193
| Metric | Q1 2015 | Q1 2014 | Q1 2013 | Q1 2012 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | — | $0.00 |
| Net Income | -$294.37K | -$501.26K | -$1.48M | -$39.34K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sunshine Biopharma Inc. · CIK 1402328 · Engraved from SEC EDGAR
ended Mar 31, 2015 · filed May 7, 2015 · 37 d after period end